// App-Quantinova.ai

[THU0398] : BENEFICIAL EFFECTS OF IN VIVO UBIQUINOL SUPPLEMENTATION ON ATHERO-THROMBOSIS PREVENTION IN ANTIPHOSPHOLIPID SYNDROME PATIENTS. PRELIMINARY RESULTS OF A CLINICAL TRIAL

Researchers

Presenter

  • C. Lopez-Pedrera

Principal Investigators

  • C. Perez-Sanchez

  • M. Aguirre

  • J. Gonzalez-Reyes

  • M. Cuadrado

  • F. Velasco

  • P. Ruiz-Limon

  • N. Barbarroja

  • Y. Jimenez-Gomez

  • P. Segui

  • E. Collantes-Estevez

  • L. Fernandez del Rio

  • J. Vilalba

Medical Centers

  • Cell Biology, Physiology and Immunology, University of Cordoba, Cordoba, Spain

  • Lupus Research Unit, St Thomas Hospital, London, United Kingdom

Locations

  • Spain

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Antiphospholipid syndrome

  • Venous thrombosis

  • Atherothrombosis

  • Coronary Artery Disease

Biomarkers

  • Coagulation Factor III, Tissue Factor

  • C-X-C motif chemokine ligand 8

  • Interleukin-8

Drug/Treatment

  • CoQ10

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved